Perimeter Solutions (PRM) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
23 Nov, 2025Executive summary
Q2 2025 net sales rose 28% year-over-year to $162.6M, driven by strong Fire Safety and Specialty Products performance, with adjusted EBITDA up 41% to $91.3M and gross profit up 39% to $101.5M.
Adjusted EPS for Q2 2025 was $0.39, up from $0.25 in Q2 2024, while GAAP EPS was $(0.22) versus $0.14 prior year, reflecting significant non-recurring founder advisory fee expenses.
Net loss of $32.2M for Q2 2025 was primarily due to a $96.9M increase in founder advisory fees linked to share price appreciation.
Year-to-date net income reached $24.5M, reversing a net loss of $60.9M in the prior year period.
Operational execution, normalized U.S. fire activity, and strong international and specialty performance were key drivers.
Financial highlights
Q2 2025 consolidated revenue was $162.6M, up 28% YoY; adjusted EBITDA was $91.3M, up 41% YoY; gross margin improved to 62.4%.
Fire Safety Q2 revenue was $120.3M, up 22% YoY; adjusted EBITDA was $77.7M, up 40% YoY.
Specialty Products Q2 net sales were $42.4M, up 47% YoY; adjusted EBITDA was $13.7M, up 48% YoY.
Cash and cash equivalents at June 30, 2025, were $140.7M.
Q2 2025 GAAP loss per share was $0.22; adjusted EPS was $0.39.
Outlook and guidance
Management expects continued growth in Fire Safety from increased fire severity, longer fire seasons, and ground-based prevention.
High end of CapEx assumptions raised to $30M, reflecting strong investment opportunities.
Sufficient liquidity is expected to meet capital expenditures, working capital, and debt service requirements for at least 12 months.
Full-year tax and net working capital expectations remain unchanged; majority of cash generation expected in the second half.
Long-term assumptions include ~$40M annual interest expense, ~$20-25M tax-deductible D&A, and ~$15-30M annual capex.
Latest events from Perimeter Solutions
- 2025 revenue up 16%, adjusted EBITDA rose 18%, with MMT acquisition and higher leverage.PRM
Q4 202526 Feb 2026 - Q2 2024 sales up 67%, Adjusted EBITDA up 209%, but net income down 58% on higher advisory fees.PRM
Q2 20242 Feb 2026 - Market leadership, value-driven growth, and high barriers fuel sustained financial outperformance.PRM
UBS Global Materials Conference22 Jan 2026 - Q3 2024 sales and EBITDA more than doubled, but non-recurring charges led to a net loss.PRM
Q3 202414 Jan 2026 - Adjusted EBITDA up 190% to $280M in 2024, driven by Fire Safety and strategic investments.PRM
Q4 202418 Dec 2025 - $685M acquisition targets recurring revenue growth and market expansion in medical device manufacturing.PRM
M&A Announcement12 Dec 2025 - 2025 meeting covers director elections, say-on-pay, auditor change, and strong 2024 results.PRM
Proxy Filing2 Dec 2025 - Virtual meeting to elect directors, approve pay, and ratify KPMG as auditor.PRM
Proxy Filing2 Dec 2025 - Q1 net income surged to $56.7M on 22% sales growth and strong Fire Safety performance.PRM
Q1 202520 Nov 2025